Novel indirubin derivatives, promising anti-tumor agents inhibiting cyclin-dependent kinases.

International journal of clinical pharmacology and therapeutics

Volumn 42, Issue 11, 2004, Pages 656-658

  Merz, K H ^a   Schwahn, S ^a   Hippe, F ^a   Muhlbeyer S ^a   Jakobs, S ^a   Eisenbrand, G ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CDK2 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; ENZYME INHIBITOR; INDIRUBIN; INDOLE DERIVATIVE;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EYE TUMOR; HUMAN; METABOLISM; PHOSPHORYLATION; RETINOBLASTOMA;

ANTINEOPLASTIC AGENTS; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; ENZYME INHIBITORS; EYE NEOPLASMS; HUMANS; INDOLES; PHOSPHORYLATION; RETINOBLASTOMA; TUMOR CELLS, CULTURED;

EID: 16644361991     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42656     Document Type: Article

References (0)